Japan Clinical Nutrition Market Size, Share, and COVID-19 Impact Analysis, By Route of Administration (Oral, Enteral, and Parenteral), By Application (Cancer, Neurological Diseases, Gastrointestinal Disorders, Metabolic Disorders, Malnutrition, and Others), By End-User (Pediatric, Adults, and Geriatric), and Japan Clinical Nutrition Market Insights Forecasts 2023 – 2033

Industry: Healthcare

RELEASE DATE Jan 2024
REPORT ID SI3481
PAGES 200
REPORT FORMAT PathSoft

Japan Clinical Nutrition Market Insights Forecasts to 2033

  • The Market Size is Growing at a CAGR of 6.1% from 2023 to 2033.
  • The Japan Clinical Nutrition Market Size is Expected to Hold a Significant Share by 2033.

 

Japan Clinical Nutrition Market

Get more details on this report -

Request Free Sample PDF

 

The Japan Clinical Nutrition Market size is Expected to Hold a significant share by 2033, at a CAGR of 6.1% during the forecast period 2023 to 2033. 

 

Market Overview

Clinical nutrition focuses on the diagnosis, management, and prevention of dietary changes associated with chronic diseases and healthcare conditions. It applies the scientific disciplines of nutrition and dietetics to the treatment of outpatients and inpatients in hospital settings. Clinical nutrition assists patients with proper nutrition by maintaining an appropriate energy balance and providing adequate nutrients such as minerals, proteins, and vitamins. Medical conditions such as stress and disease may prevent the body from obtaining adequate nutrients from diet alone, necessitating the use of additional nutrients. Clinical nutrition aids in the development of focused dietary supplements tailored to an individual's specific needs to meet the demand created by a lack of proper nutrition. The increase in awareness of weight management and the benefits of healthy lifestyles is expected to drive market growth.

 

Report Coverage

This research report categorizes the market for the Japan clinical nutrition market based on various segments and regions forecasts revenue growth and analyzes trends in each submarket. The report analyses the key growth drivers, opportunities, and challenges influencing the Japan clinical nutrition market. Recent market developments and competitive strategies such as expansion, product launch, and development, partnership, merger, and acquisition have been included to draw the competitive landscape in the market. The report strategically identifies and profiles the key market players and analyses their core competencies in each sub-segment of the Japan clinical nutrition market.                 

 

Japan Clinical Nutrition Market Report Coverage

Report CoverageDetails
Base Year:2023
Forecast Period:2023 - 2033
Forecast Period 2023 - 2033 CAGR:6.1%
Historical Data for:2019 - 2022
No. of Pages:200
Tables, Charts & Figures:110
Segments covered:By Route of Administration, By Application, By End-User and COVID-19 Impact Analysis
Companies Covered: Otsuka Holdings Co. Ltd., Meiji Holding Co., Ltd., Glanbia Japan K.K., DSM Japan Nutrition K.K., Nestle Japan, Fresenius Medical Care Japan, Abbott Japan Co., Ltd., Danone Japan Co., Ltd., Grifols Japan K.K., and Others
Pitfalls & Challenges:COVID-19 Empact, Challenge, Future, Growth, & Analysis

Get more details on this report -

Request Free Sample PDF
 

Driving Factors

Growing working professionals and the trend toward sedentary lifestyles leave less time for proper nutrition management. The increase in the number of obese people as a result of unhealthy eating habits, as well as the rising rate of premature births, boosts the clinical nutrition industry, while middle-class families' economic conditions and disposable income improve, allowing them to afford appropriate healthcare facilities. The expansion of the healthcare sector, as well as increased patient access to information about the benefits of dietary supplement consumption, are expected to drive market growth.

 

Restraining Factors

Though demand for clinical nutrition is increasing, a lack of awareness about healthcare and diet has been observed, and there is still a lack of understanding about clinical nutrition for various illnesses. As a consequence, the market is expected to suffer due to a lack of awareness about clinical nutrition.

 

Market Segment

  • In 2023, the enteral segment accounted for the largest revenue share over the forecast period.

Based on the route of administration, the Japan clinical nutrition market is segmented into oral, enteral, and parenteral. Among these, the enteral segment has the largest revenue share over the forecast period. The rise in the prevalence of chronic diseases such as cancer and neurological disorders is the primary driver of the enteral nutrition market. Furthermore, the growing geriatric population, rising malnutrition rates, technological advancements, and the incorporation of appropriate ingredients into product formulations will drive market growth.

 

  • In 2023, the cancer segment is witnessing significant growth over the forecast period.

Based on application, the Japan clinical nutrition market is segmented into cancer, neurological diseases, gastrointestinal disorders, metabolic disorders, malnutrition, and others. Among these, the cancer segment is witnessing significant growth over the forecast period. This is due to the side effects of cancer on normal eating and nutrition in the body. Furthermore, nutritional deficiency is a common medical issue, affecting 15-40% of cancer patients. Nutrition therapy assists cancer patients in maintaining a healthy body weight, maintaining strength, protecting body tissue, and reducing side effects during and after treatment.

 

  • In 2023, the geriatric segment accounted for the largest revenue share over the forecast period.

Based on end users, the Japan clinical nutrition market is segmented into pediatric, adult, and geriatric. Among these, the geriatric segment has the largest revenue share over the forecast period. The geriatric population is vulnerable to a variety of chronic diseases due to a lack of nutritional intake through food. Other factors include an increase in sarcopenia, weakness, organ dysfunction, low immunity, and osteoporosis. People with chronic diseases like cancer and diabetes, as well as the growing geriatric population, are expected to contribute to market growth.

 

Competitive Analysis:

The report offers the appropriate analysis of the key organizations/companies involved within the Japan clinical nutrition market along with a comparative evaluation primarily based on their product offering, business overviews, geographic presence, enterprise strategies, segment market share, and SWOT analysis. The report also provides an elaborative analysis focusing on the current news and developments of the companies, which includes product development, innovations, joint ventures, partnerships, mergers & acquisitions, strategic alliances, and others. This allows for the evaluation of the overall competition within the market.

 

List of Key Companies

  • Otsuka Holdings Co. Ltd.
  • Meiji Holding Co., Ltd.
  • Glanbia Japan K.K.
  • DSM Japan Nutrition K.K.
  • Nestle Japan
  • Fresenius Medical Care Japan
  • Abbott Japan Co., Ltd.
  • Danone Japan Co., Ltd.
  • Grifols Japan K.K.
  • Others

 

Key Target Audience

  • Market Players
  • Investors
  • End-users
  • Government Authorities 
  • Consulting and Research Firm
  • Venture capitalists
  • Value-Added Resellers (VARs)

 

Market Segment

This study forecasts revenue at regional, and country levels from 2022 to 2033. Spherical Insights has segmented the Japan Clinical Nutrition Market based on the below-mentioned segments:   

     

Japan Clinical Nutrition Market, By Type

  • Oral
  • Enteral
  • Parenteral

 

Japan Clinical Nutrition Market, By Application

  • Cancer
  • Neurological Diseases
  • Gastrointestinal Disorders
  • Metabolic Disorders
  • Malnutrition
  • Others

 

Japan Clinical Nutrition Market, By End User

  • Pediatric
  • Adults
  • Geriatric

Need help to buy this report?

Inquiry Before Buy
We'll use cookies to improve and customize your experience if you continue to browse. Is it OK if we also use cookies to show you personalized ads?
Learn more and manage your cookies
Yes, Accept Cookies